Cornerstone Wealth Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cornerstone Wealth Group, LLC

$1.21 Billion
Q2 2024

A detailed history of Cornerstone Wealth Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cornerstone Wealth Group, LLC holds 3,718 shares of REGN stock, worth $3.87 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

3,718

Previous 3,614 2.88%

Holding current value

$3.87 Million

Previous $3.48 Million 12.33%

% of portfolio

0.32%

Previous 0.3%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$883.2 - $1071.19 $91,852 - $111,403	104 Added 2.88%	3,718 $3.91 Million
Q1 2024 Apr 17, 2024	SELL	$902.69 - $993.35 $1.32 Million - $1.45 Million	-1,457 Reduced 28.73%	3,614 $3.48 Million
Q4 2023 Jan 29, 2024	SELL	$775.18 - $881.7 $86,044 - $97,868	-111 Reduced 2.14%	5,071 $4.45 Million
Q3 2023 Oct 18, 2023	SELL	$692.45 - $844.37 $60,243 - $73,460	-87 Reduced 1.65%	5,182 $4.26 Million
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $71,403 - $84,695	102 Added 1.97%	5,269 $3.79 Million
Q1 2023 Apr 25, 2023	SELL	$680.49 - $826.97 $41,509 - $50,445	-61 Reduced 1.17%	5,167 $4.25 Million
Q4 2022 Jan 25, 2023	SELL	$705.89 - $766.39 $50,118 - $54,413	-71 Reduced 1.34%	5,228 $0
Q3 2022 Oct 19, 2022	BUY	$573.97 - $724.32 $3.04 Million - $3.84 Million	5,299 New	5,299 $3.65 Million
Q4 2021 Jan 25, 2022	SELL	$543.48 - $670.97 $2.66 Million - $3.29 Million	-4,902 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$574.03 - $680.96 $2.81 Million - $3.34 Million	4,902 New	4,902 $2.97 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Group, LLC with notifications on news.

Account

Cornerstone Wealth Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History